Purpose
Atrial fibrillation (AF) is more prevalent in men than women. Due to these sex differences in AF susceptibility, we examined whether sex hormones have differing associations with AF risk in men and women.
Methods
This analysis included 4,883 (mean age=63±10 years; 39% women; 64% non-white) participants from the Multi-Ethnic Study of Atherosclerosis. Sex hormones (total testosterone, bioavailable testosterone, estradiol, and sex hormone binding globulin (SHBG)) were measured at baseline (2000–2002) for all male and all postmenopausal female participants. AF was ascertained by hospital discharge records, Medicare claims data, and study electrocardiograms through December 31, 2012.
Results
Over a median follow-up of 10.9 years, a total of 613 (13%) AF cases were detected. A higher incidence rate of AF was observed for males (n=385, age-standardized incidence rate per 1000 person-years=12.3, 95%CI=11.1, 13.6) than females (n=228, age-standardized incidence rate per 1000 person-years=9.0, 95%CI=7.9, 10.3). In men, higher bioavailable testosterone levels were associated with increased AF risk (HR=1.32, 95%CI=1.01, 1.74; p=0.044; comparing 3rd to 1st tertile), while an association in the opposite direction was observed for women (HR=0.81, 95%CI=0.58, 1.13; p=0.22; comparing 3rd to 1st tertile). Other hormones were not associated with AF in men or women.
Conclusion
Higher levels of endogenous bioavailable testosterone contribute to AF development in men. The combination of endogenous bioavailable testosterone and other risk factors potentially are important for AF development in men.